Back to trial details

Intake questionnaire

Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib

Applying to University of Chicago Medicine Comprehensive Cancer Center · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Lung Cancer?
3. Are you able to travel to Chicago for study visits?